- Patients who experienced an allergic reaction to the first dose of their COVID-19 vaccine will receive their second dose with graded dosing.
- President Biden endorsed making all adults eligible for COVID-19 vaccines by April 19. This will likely create a surge in demand for vaccines.
- The Department of Health and Human Services (HHS) launched a new website to promote vaccination among minority communities.
- The CDC updated its guidelines including People with Moderate to Severe Asthma; U.S. COVID-19 Cases Caused by Variants; Long-Term Effects of COVID-19; and COVID-19 Vaccination Toolkits.
White House and Federal Agencies
- President Biden endorsed making all adults eligible for COVID-19 vaccines by April 19. This will likely create a surge in demand for vaccines.
- The Centers for Disease Control and Prevention (CDC) will begin distributing $3.1 billion in American Rescue Plan funding to mass vaccination sites.
- The Department of Health and Human Services (HHS) launched a new website to promote vaccination among minority communities.
- President Biden appointed Gayle Smith, former United States Agency for International Development’s (USAID) Administrator, to lead the federal government’s global COVID-19 response.
Centers for Disease Control and Prevention (CDC) Updates
- The CDC says a variant of COVID-19 that first originated the United Kingdom is now the most common form of COVID-19 in the U.S.
- The CDC updated its websites for:
- Cases in the U.S.
- Provisional Mortality Data – United States, 2020
- Overall US COVID-19 Vaccine Distribution and Administration Update as of Thu, 08 Apr 2021 06:00:00 EST
- Variant Proportions in the U.S.
- U.S. COVID-19 Cases Caused by Variants
- COVID-19 Vaccination Toolkits
- Requirement for Proof of Negative COVID-19 Test or Recovery from COVID-19 for All Air Passengers Arriving in the United States
- What to Expect at Your Appointment to Get Vaccinated for COVID-19
- Long-Term Effects of COVID-19
- COVID-19 Vaccines that Require 2 Shots
- Reporting COVID-19 Vaccinations in the United States
- Ensuring the Safety of COVID-19 Vaccines in the United States
- People with Moderate to Severe Asthma
- Customizable COVID-19 Vaccination Content for Health Departments and Other Public Health Partners
- Resources for Sharing Real-Time Vaccine Information
- Reporting County-Level COVID-19 Vaccination Data
- Testing Data in the U.S.
- Selected Adverse Events Reported after COVID-19 Vaccination
- Improve How Your Mask Protects You
Economy, Vaccines, Testing and Treatment
- One in four U.S. adults are now fully vaccinated against COVID-19.
- Antibodies remained present after six months from receiving two doses of Moderna’s COVID-19 vaccine.
- Distributions of Johnson & Johnson’s vaccine will be lower next week due to manufacturing issues that caused 15 million doses to be disposed.
- The National Institute of Allergy and Infectious Diseases (NIAID) began studying allergic reactions to the Pfizer-BioNTech and Moderna vaccines.
- Patients who experienced an allergic reaction to the first dose of their COVID-19 vaccine will receive their second dose with graded dosing.
- The United Kingdom imposed some restrictions on who can receive AstraZeneca’s COVID-19 vaccine due to a low risk of blood clots. European Union regulators reiterated their confidence in the vaccine’s safety.
- New research was published on multiple inflammatory syndrome (MIS-C), which can affect children who were diagnosed with COVID-19.
- NIAID Director Dr. Anthony Fauci warned that we are headed for a new surge in cases.
- Hospitals are reporting more young adults with severe COVID-19 symptoms.
- White House Press Secretary Jen Psaki said the White House does not currently support a government requirement for vaccination passports.
- The World Health Organization (WHO) also does not currently support requiring vaccination passports for international travel.
